Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
89
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study

Wenxia HuDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of China
,
Bin LiDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of China
,
Nan GengDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-8953-1438
ORCID Icon,
Xin HeDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of China
,
Hui GeDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of China
,
Ping WangDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of China
&
Cuimin DingDepartment of Respiratory Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang050011, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2703-2714 | Published online: 21 Jun 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wen-Xia Hu, Jing-Cui Peng, Yun Wang, Hao Jin & Nan Geng. (2022) Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study. International Journal of General Medicine 15, pages 4453-4464.
Read now
Hong-Tao Jiang, Wei Li, Biao Zhang, Qiang Gong & Hai-Ling Qie. (2021) Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study. International Journal of General Medicine 14, pages 7625-7637.
Read now

Articles from other publishers (5)

Mohamed I. Sakran, Adel I. Alalawy, Amnah A. Alharbi, Mohamed E. El-Hefnawy, Salem M. Alzahrani, Ahmed Alfuraydi, Fahad Mohammed Alzuaibr, Nahla S. Zidan, Afaf M. Elsaid, Eman A. Toraih & Rami M. Elshazli. (2023) The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility. International Immunopharmacology 125, pages 111180.
Crossref
Zhaodan Xin, Liting You, Jin Li, Feifei Na, Min Chen, Jiajia Song, Ling Bai, Hao Chen, Jianzhao Zhai, Xiaohan Zhou, Juan Zhou & Binwu Ying. (2023) Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade. International Immunopharmacology 121, pages 110469.
Crossref
Jijin Wang, Di Huang, Wenjing Yang, Qingxu Song, Yibin Jia, Pengxiang Chen & Yufeng Cheng. (2022) The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial. Frontiers in Oncology 12.
Crossref
Xiao-Ping Li, Wei-Dong Zhang, Ming-Jiang Li, Juan Wang, Jie Lian & Hong-Gang Zhou. (2022) Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study. Journal of Oncology 2022, pages 1-10.
Crossref
Wan Qin, Ben Zhao, Duanrui Wang, Jiamin Liu, Yilu Zhou, Wenjun Zhu, Yongbiao Huang, Hong Qiu & Xianglin Yuan. (2022) A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy. Frontiers in Oncology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.